| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Department of Psychiatry (Drs. Schnaider Beeri and Silverman) and Biomathematical Sciences Department (Dr. Schmeidler), Mount Sinai School of Medicine, New York, NY; Division of Epidemiology and Preventive Medicine (Dr. Goldbourt), Sackler Medical Faculty, Tel Aviv University; and Neufeld Cardiac Research Institute (Dr. Goldbourt) and Department of Psychiatry (Drs. Noy, Ravona-Springer, Sverdlick, and Davidson), Sheba Medical Center, Tel Hashomer, Israel.
Address correspondence and reprint requests to Dr. Michal Schnaider Beeri, Mount Sinai School of Medicine, Department of Psychiatry, One Gustave Levy Place, Box 1230, New York, NY 10029; e-mail: michal.beeri{at}mssm.edu
Objective: To examine the association between diabetes in midlife (1963–1968) and dementia more than three decades later (1999–2001).
Methods: The authors characterized dementia using standard methods for 1,892 participants among 2,606 survivors of 10,059 participants in the Israeli Ischemic Heart Disease study, a longitudinal investigation of the incidence of and risk factors for cardiovascular disease among Jewish male civil servants in Israel. Face to face interviews were conducted with the 652 subjects identified as possibly demented by the Modified Telephone Interview for Cognitive Status. Logistic regression analysis was performed to assess the association of diabetes with dementia controlling for sociodemographic and cardiovascular variables compared to those with no cognitive impairment.
Results: Of 1,892 assessed subjects (mean age 82 at assessment), 309 (16.3%) had dementia. Diabetic subjects had significantly more dementia than non-diabetic subjects (
2 = 7.54, df = 1, p = 0.006, OR 2.83 [95% CI = 1.40 to 5.71]). Those who survived to the time of this study were younger and healthier than those who died.
Conclusions: Evidence for diabetes as a risk factor for dementia was found, similar to other epidemiologic studies. In contrast to the earlier studies, however, the authors linked diabetes in midlife to dementia more than three decades later in the very old survivors of a large male cohort.
Received October 3, 2003. Accepted in final form July 16, 2004.
This article has been cited by other articles:
|
|
 |
|
  F.-F. Liao and H. Xu Insulin Signaling in Sporadic Alzheimer's Disease Sci. Signal., June 9, 2009; 2(74): pe36 - pe36. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Chen, K. Zhou, R. Wang, Y. Liu, Y.-D. Kwak, T. Ma, R. C. Thompson, Y. Zhao, L. Smith, L. Gasparini, et al. Antidiabetic drug metformin (GlucophageR) increases biogenesis of Alzheimer's amyloid peptides via up-regulating BACE1 transcription PNAS, March 10, 2009; 106(10): 3907 - 3912. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Xu, C. Qiu, M. Gatz, N. L. Pedersen, B. Johansson, and L. Fratiglioni Mid- and Late-Life Diabetes in Relation to the Risk of Dementia: A Population-Based Twin Study Diabetes, January 1, 2009; 58(1): 71 - 77. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Coley, S. Andrieu, V. Gardette, S. Gillette-Guyonnet, C. Sanz, B. Vellas, and A. Grand Dementia Prevention: Methodological Explanations for Inconsistent Results Epidemiol. Rev., November 1, 2008; 30(1): 35 - 66. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Ronnemaa, B. Zethelius, J. Sundelof, J. Sundstrom, M. Degerman-Gunnarsson, C. Berne, L. Lannfelt, and L. Kilander Impaired insulin secretion increases the risk of Alzheimer disease Neurology, September 30, 2008; 71(14): 1065 - 1071. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. S. Beeri, J. Schmeidler, J. M. Silverman, S. Gandy, M. Wysocki, C. M. Hannigan, D. P. Purohit, G. Lesser, H. T. Grossman, and V. Haroutunian Insulin in combination with other diabetes medication is associated with less Alzheimer neuropathology Neurology, September 2, 2008; 71(10): 750 - 757. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Xu, C. Qiu, B. Winblad, and L. Fratiglioni The Effect of Borderline Diabetes on the Risk of Dementia and Alzheimer's Disease Diabetes, January 1, 2007; 56(1): 211 - 216. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Arvanitakis, J. A. Schneider, R. S. Wilson, Y. Li, S. E. Arnold, Z. Wang, and D. A. Bennett Diabetes is related to cerebral infarction but not to AD pathology in older persons Neurology, December 12, 2006; 67(11): 1960 - 1965. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. J. Clodfelder-Miller, A. A. Zmijewska, G. V.W. Johnson, and R. S. Jope Tau Is Hyperphosphorylated at Multiple Sites in Mouse Brain In Vivo After Streptozotocin-Induced Insulin Deficiency Diabetes, December 1, 2006; 55(12): 3320 - 3325. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Akomolafe, A. Beiser, J. B. Meigs, R. Au, R. C. Green, L. A. Farrer, P. A. Wolf, and S. Seshadri Diabetes Mellitus and Risk of Developing Alzheimer Disease: Results From the Framingham Study Arch Neurol, November 1, 2006; 63(11): 1551 - 1555. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. S. Beeri, M. Rapp, J. M. Silverman, J. Schmeidler, H. T. Grossman, J. T. Fallon, D. P. Purohit, D. P. Perl, A. Siddiqui, G. Lesser, et al. Coronary artery disease is associated with Alzheimer disease neuropathology in APOE4 carriers Neurology, May 9, 2006; 66(9): 1399 - 1404. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Aragno, R. Mastrocola, C. Medana, F. Restivo, M. G. Catalano, N. Pons, O. Danni, and G. Boccuzzi Up-Regulation of Advanced Glycated Products Receptors in the Brain of Diabetic Rats Is Prevented by Antioxidant Treatment Endocrinology, December 1, 2005; 146(12): 5561 - 5567. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
